The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Refinement of prespecified cutoff for genomic loss of heterozygosity (LOH) in ARIEL2 part 1: A phase II study of rucaparib in patients (pts) with high grade ovarian carcinoma (HGOC).
 
Robert L. Coleman
Honoraria - NCCN
Consulting or Advisory Role - Clovis Oncology; DOD-CDRMP; Esperance Pharmaceuticals; Genentech/Roche; NCCN
Research Funding - Amgen; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merrimack; OncoMed
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Bayer; Clovis Oncology; Gradalis; Merck; Merrimack; Millennium
 
Elizabeth M. Swisher
Travel, Accommodations, Expenses - Clovis Oncology
 
Amit M. Oza
Honoraria - WebRx
Consulting or Advisory Role - Amgen; Clovis Oncology; Immunovaccine; Verastem
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Clare L. Scott
Honoraria - AstraZeneca; Eisai; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai
Speakers' Bureau - Prime Oncology
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Roche
Other Relationship - Clovis Oncology
 
Heidi Giordano
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Kevin K. Lin
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Gottfried E. Konecny
Consulting or Advisory Role - Novartis
Research Funding - Amgen; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Anna Tinker
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca/MedImmune (Inst)
 
David M. O'Malley
Consulting or Advisory Role - Eisai; Janssen Oncology
Research Funding - Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Immunogen (Inst); Janssen Research & Development (Inst); Regeneron (Inst); VentiRx (Inst)
 
Rebecca Sophie Kristeleit
Honoraria - AstraZeneca; Clovis Oncology; Roche/Genentech
Consulting or Advisory Role - Clovis Oncology; Lytix Biopharma; Roche/Genentech; Sotio
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; PiQuR
 
Ling Ma
Consulting or Advisory Role - bioTheranostics
 
Katherine M. Bell-McGuinn
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
Travel, Accommodations, Expenses - Abbvie
 
James D. Brenton
Stock and Other Ownership Interests - Inivata
Consulting or Advisory Role - Inivata
Speakers' Bureau - AstraZeneca
Patents, Royalties, Other Intellectual Property - TAm-Seq v2 method for ctDNA estimation
Travel, Accommodations, Expenses - Aprea AB; Clovis Oncology
 
Janiel M. Cragun
Research Funding - Clovis Oncology (Inst)
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
Isabelle Laure Ray-Coquard
Consulting or Advisory Role - AstraZeneca; MSD; PharmaMar; Roche
Travel, Accommodations, Expenses - PharmaMar; Roche
 
Scott H. Kaufmann
No Relationships to Disclose
 
Sandra Goble
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Lara Maloney
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Iain A. McNeish
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
Research Funding - Clovis Oncology (Inst)